Islanda -
islandese -
LYFJASTOFNUN (Icelandic Medicines Agency)
menopur stungulyfsstofn og leysir, lausn 75 a.e.
ferring lægemidler a/s - menotrophin hp - stungulyfsstofn og leysir, lausn - 75 a.e.
Islanda -
islandese -
LYFJASTOFNUN (Icelandic Medicines Agency)
metronidazol normon innrennslislyf, lausn 5 mg/ml
laboratorios normon, s.a. - metronidazolum inn - innrennslislyf, lausn - 5 mg/ml
Islanda -
islandese -
LYFJASTOFNUN (Icelandic Medicines Agency)
zesuva (sunitinib alvogen) hart hylki 12,5 mg
zentiva k.s.* - sunitinibum inn - hart hylki - 12,5 mg
Islanda -
islandese -
LYFJASTOFNUN (Icelandic Medicines Agency)
zesuva (sunitinib alvogen) hart hylki 25 mg
zentiva k.s.* - sunitinibum inn - hart hylki - 25 mg
Islanda -
islandese -
LYFJASTOFNUN (Icelandic Medicines Agency)
zesuva (sunitinib alvogen) hart hylki 50 mg
zentiva k.s.* - sunitinibum inn - hart hylki - 50 mg
Unione Europea -
islandese -
EMA (European Medicines Agency)
vafseo
akebia europe limited - vadadustat - renal insufficiency, chronic; anemia - sýklalyf - vafseo is indicated for the treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.
Islanda -
islandese -
LYFJASTOFNUN (Icelandic Medicines Agency)
menopur stungulyf, lausn í áfylltum lyfjapenna 1200 a.e.
ferring lægemidler a/s - menotropinum - stungulyf, lausn í áfylltum lyfjapenna - 1200 a.e.
Islanda -
islandese -
LYFJASTOFNUN (Icelandic Medicines Agency)
menopur stungulyf, lausn í áfylltum lyfjapenna 600 a.e.
ferring lægemidler a/s - menotropinum - stungulyf, lausn í áfylltum lyfjapenna - 600 a.e.